Primary colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Van Cutsem, E ^a   Oliveira, J ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLON SURGERY; DRUG DOSE REGIMEN; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; EUROPE; FOLLOW-UP STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 66549099437     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp126     Document Type: Article

References (12)

1. Ferlay J, Autier P, Moniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
2. O'Connell J, Maggard M, Ko C. Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging. J Natl Cancer Inst 2004; 96: 1420-1425.
3. Greene F, Stewart A, Norton H. A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50042 patients. Ann Surg 2003; 236: 416-421.
4. Moertel CG, Fleming TR, Macdonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 1995; 122: 321-326.
5. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-2351.
6. Benson A, Schrag D, Somerfield M et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004; 22: 1-12.
7. Twelves C, Wong A, Nowacki M et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005; 352: 2696-2704.
8. Van Cutsem E, Tejpar S, Verslype C, Laurent S. Challenges in the adjuvant treatment for patients with stages II and III colon cancer. ASCO Educational Book 2006: 179-186.
9. Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 2007; 370: 2020-2029.
10. Sargent DJ, Patiyil S, Yothers G et al. End points for colon cancer adjuvant trials: Observations and recommendations based on individual patient data from 20 898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol 2007; 25: 4569-4574.
11. Pfister D, Benson A, Somerfield M. Surveillance strategies after curative treatment of colorectal cancer. New Engl J Med 2004; 350: 2375-2382.
12. Desch C, Benson A, Somerfield M et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology Practise Guideline. J Clin Oncol. 23. 2005; 8512-8519.